Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products

Diabetes

Volumn 47, Issue 6, 1998, Pages 945-952

  Chakravarthy, Usha ^a   Hayes, Ruth G ^a   Stitt, Alan W ^a   McAuley, Edel ^a   Archer, Desmond B ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; ENZYME ANALYSIS; ENZYME INHIBITION; GLYCATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; VASCULAR ENDOTHELIUM;

EID: 0031831261     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.6.945     Document Type: Article

References (38)

1. Feke GT, Buzney SM, Ogasawara H, Fujio N, Goger DG, Spack NP, Gabbay KH: Retinal circulatory abnormalities in type 1 diabetes. Invest Ophthalmol 35:2968-2975, 1994
2. Bank N, Aynedgian HS: Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 40:1306-1312, 1993
3. Moncada S, Palmer RMJ, Higgs AE: The discovery of nitric oxide as the endogenous nitrosovasodilator. Hypertension 12:365-372, 1988
4. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P: Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 94:2511-2515, 1994
5. Palmer RMJ, Ferridge AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 333:664-666, 1988
6. Chakravarthy U, Stitt AW, McNally J, Bailie JR, Hoey EM, Duprex P: Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes. Curr Eye Res 14:285-294, 1995
7. Ostwald P, Goldstein IM, Pachnanda A, Roth S: Effect of nitric oxide synthase inhibition on blood flow after retinal ischaemia in cats. Invest Ophthalmol 36:2396-2403, 1995
8. Schmetterer L, Krejcy K, Kastner J, Wolzt M, Gouya G, Findl O, Lexer F, Breiteneder H, Fercher AF, Eichler HG: The effect of systemic nitric oxide synthase inhibition on ocular fundus pulsations in man. Exp Eye Res 64:305-312, 1997
9. Wang Y, Marsden PA: Nitric oxide syntheses: biochemical and molecular regulation. Curr Opin Nephrol Hypertens 4:12-22, 1995
10. Pieper GM, Moore-Hilton G, Roza AM: Evaluation of the mechanism of endothelial dysfunction in the genetically-diabetic BB rat. Life Sci 58: PL147-PL152, 1996
11. Pieper GM: Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin. J Cardiovasc Pharm 29:8-11, 1997
12. Angulo J, Sanchezferrer CF, Peiro C, Marin J, Rodriguezmanas L: Impairment of endothelium-dependent relaxation by increasing percentages of glycosylated hemoglobin: possible mechanisms involved. Hypertension 28:583-592, 1996
13. Bucala R, Vlassara H, Cerami A: Advanced glycosylation endproducts. In Post-Translational Modifications of Proteins, Vol. 2. Harding JJ, Crabbe MJC Eds. Boca Raton, FL, CRS Press, 1992, p. 53-59
14. Bucala R, Tracey KJ, Cerami A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87:432-438, 1991
15. Hogan M, Cerami A, Bucala R: Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. J Clin Invest 90:1110-1115, 1992
16. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TR Moore WM, Currie MG, Corbett JA, McDaniel ML, Williamson JR: Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42:221-232, 1993
17. Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Bucala R: Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci USA 89:12043-12047, 1992
18. Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H: Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and AGE-infused rats. Am J Pathol 150:523-531, 1997
19. Chakravarthy U, Gardiner TA, Anderson P, Archer DB, Trimble ER: The effect of endothelin 1 on the retinal microvascular pericyte. Microvasc Res 43:241-254, 1992
20. Tsukahara H: Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells. Biochem Biophys Res Comm 193:722-729, 1993
21. Gross SS, Jaffe EA, Levi R, Kilbourn RG: Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. Biochem Biophys Res Comm 178:823-829, 1991
22. Yang Z, Makita Z, Horii Y, Brunelle S, Cerami A, Sehajpal P, Suthanthiran M, Vlassara H: Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage scavenger receptor for glucose modified proteins. J Exp Med 174:515-524, 1991
23. Makita Z, Vlassara H, Cerami A, Bucala R: Immunological detection of advanced glycosylation end products in vivo. J Biol Chem 267:5133-5138, 1992
24. Chomczynski P, Saatchi N: Single step method of RNA isolation by acid-guanidinium thiocyanate phenol chloroform extraction. Anal Biochem 162:156-159, 1987
25. Craven PA, Studer RK, DeRubertis FR: Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats: evidence for protein kinase C-mediated suppression of the cholinergic response. J Clin Invest 93:311-320, 1994
26. Bulgrin JP, Shabani M, Chakravarthy D, Smith DJ: Nitric oxide synthesis is suppressed in steroid-impaired and diabetic wounds. Wounds, A Compendium Of Clinical Research and Practice 7:48-57, 1995
27. Okuda Y, Kawashima K, Suzuki S, Asakura Y, Asano M, Tsurumaru K, Dai HQ, Tachi Y, Bannai C, Saitoh M, Yamashita K: Restoration of nitric oxide production by aldose reductase inhibitor in human endothelial cells cultured in high-glucose medium. Life Sci 60:PL53-P156, 1996
28. Eizirik DL, Leijerstam F: The inducible form of nitric oxide synthase (iNOS) in insulin-producing cells. Diabete Metab 20:116-122, 1994
29. Sharma K, Danoff TM, Depiero A, Ziyadeh FN: Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation by protein kinase C. Biochem Biophys Res Comm 207:80-68, 1995
30. Schonfelder G, John M, Hopp H, Fuhr N, van Der Giet M, Paul M: Expression of inducible nitric oxide synthase in placenta of women with gestational diabetes. FASEB J 10:777-784, 1996
31. Lamas S, Marsden PA, Li GK, Tempst P, Michel T: Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive isoform. Proc Natl Acad Sci USA 89:6348-6352, 1992
32. Graier WF, Wascher TC, Lackner L, Toplak H, Krejs GJ, Kukovetz WR: Exposure to elevated D-glucose concentrations modulates vascular endothelial cell vasodilatory response. Diabetes 42:1497-1505, 1993
33. Giardino I, Edelstein D, Brownlee M: Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity: a model for intracellular glycosylation in diabetes. J Clin Invest 94:110-117, 1994
34. Li YM, Mitsuhashi T, Wojciehowicz D, Shimizu N, Li J, Stitt AW, He C, Banerjee D, Vlassara H: Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and 80K-H membrane proteins. Proc Natl Acad Sci USA 93:11047-11052, 1996
35. King GL, Shiba T, Feener EP, Nayak R: Cell culture model for the study of vascular complications of diabetes: the effect of high glucose levels on metabolism and growth of vascular cells. In Hyperglycemia, Diabetes and Vascular Disease. Ruderman N, Brownlee M, Eds. Oxford University Press, Oxford, U.K., 1992
36. Ohara Y, Sayegh SS, Yamn JJ, Harrison DG: Regulation of endothelial constitutive nitric oxide synthase by protein kinase C. Hypertension 25:415-420, 1995
37. Hirata KI, Kuroda R, Sakoda T, Katayama M, Inoue N, Suematsu M, Kawashima S, Yokoyama M: Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension 25:180-185, 1995
38. Lee TS, Saltsman KA, Ohashi H, King GL: Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci US4 86:5141-5145, 1989